MedTrace Logo

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults

NCT07695441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-07-10

No results posted yet for this study

Summary

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.

Conditions

  • Postprandial Glycemic Response
  • Healthy Adults

Interventions

BEHAVIORAL

Walking Without Bot-Fit

Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.

DEVICE

Bot-Fit Aqua Mode

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.

DEVICE

Bot-Fit Boost Mode

Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.

Sponsors & Collaborators

  • Samsung Electronics

    collaborator INDUSTRY

  • CHA University

    lead OTHER

Principal Investigators

  • Seung-Bo Park, Ph.D · CHA University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-17
Primary Completion
2026-04-25
Completion
2026-04-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07695441 on ClinicalTrials.gov